J. W. Nelson, Plummer, M. S., Blount, K. F., Ames, T. D., and Breaker, R. R., “Small molecule fluoride toxicity agonists.”, Chem Biol, vol. 22, no. 4, pp. 527-34, 2015.
K. F. Blount, Megyola, C., Plummer, M., Osterman, D., O'Connell, T., Aristoff, P., Quinn, C., R Chrusciel, A., Poel, T. J., Schostarez, H. J., Stewart, C. A., Walker, D. P., Wuts, P. G. M., and Breaker, R. R., “Novel Riboswitch-Binding Flavin Analog That Protects Mice against Clostridium difficile Infection without Inhibiting Cecal Flora.”, Antimicrob Agents Chemother, vol. 59, no. 9, pp. 5736-46, 2015.
J. N. Kim, Blount, K. F., Puskarz, I., Lim, J., Link, K. H., and Breaker, R. R., “Design and antimicrobial action of purine analogues that bind Guanine riboswitches.”, ACS Chem Biol, vol. 4, no. 11, pp. 915-27, 2009.
E. R. Lee, Blount, K. F., and Breaker, R. R., “Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression.”, RNA Biol, vol. 6, no. 2, pp. 187-94, 2009.
K. F. Blount, Wang, J. Xin, Lim, J., Sudarsan, N., and Breaker, R. R., “Antibacterial lysine analogs that target lysine riboswitches.”, Nat Chem Biol, vol. 3, no. 1, pp. 44-9, 2007.
K. F. Blount and Breaker, R. R., “Riboswitches as antibacterial drug targets.”, Nat Biotechnol, vol. 24, no. 12, pp. 1558-64, 2006.
K. Blount, Puskarz, I., Penchovsky, R., and Breaker, R., “Development and application of a high-throughput assay for glmS riboswitch activators.”, RNA Biol, vol. 3, no. 2, pp. 77-81, 2006.